Karayan et al. suggested that SEMA3G might be used as a prognostic marker in glial tumours [5]; Zhou et al. confirmed that SEMA3G possessed anti-migration and anti-invasion abilities in glioma cells [6]. This evidence concerns the gene SEMA3G and central nervous system cancer.